Guest guest Posted June 25, 2008 Report Share Posted June 25, 2008 Dear having referred the site you have mentioned of IJP, my comments would be the following. The key-words in the research paper are 'poly-herbal preparation NR-ANX-C' and 'anti-anxiety activity' , the title of this paper being 'Anti-anxiety activity of NR-ANX-C, a poly-herbal preparation in rats'. So, the points to be thought of would be - 1) It is a poly-herbal preparation and not plain, whole Ashwagandha; the obvious term poly-herbal indicating more than one herb. 2) The action targeted is anti-anxiolytic and not sedative. Pharmacologically, these are two distinctly seperate actions. 3) The study has been done on Wistar albino rats and not humans. Hence it indicates that the study is in very much preliminary stage to qualify for confirmed pharmacological and clinical activity. 4) Moreover, nowhere in the abstract is the mention of words Ashwagandha or sedative, which are the main subject of our discussion. Your parameters of my failure have no importance for me, when you yourself are not on a firm and authentic footing. Dr.D.B.Muzumdar M.D.Ayurveda-Medicine (Mumbai-India) _______________ Perhaps read the quote again: one is an isolated extract, one is a methanolic extract, and one is a commercial preparation. Recently, the IJP published another study suggesting that Withania has a diazepam like activity: http://tiny.cc/cro2G Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.